Cargando…

Targeted Nanoparticles for Pediatric Leukemia Therapy

The two major forms of leukemia, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), account for about one-third of the malignancies diagnosed in children. Despite the marked successes in ALL and AML treatment, concerns remain regarding the occurrence of resistant disease in subsets...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basha, Riyaz, Sabnis, Nirupama, Heym, Kenneth, Bowman, W. Paul, Lacko, Andras G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026702/ https://www.ncbi.nlm.nih.gov/pubmed/24860784 http://dx.doi.org/10.3389/fonc.2014.00101

Ejemplares similares

Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma
por: Sabnis, Nirupama, et al.
Publicado: (2013)

Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles
por: Xiong, Fangyuan, et al.
Publicado: (2017)

Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
por: Mooberry, Linda K., et al.
Publicado: (2016)

Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
por: Sabnis, Sarika, et al.
Publicado: (2017)

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles
por: Sabnis, Nirupama, et al.
Publicado: (2012)

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
por: Johnson, Rebecca, et al.
Publicado: (2017)

The SR-B1 Receptor as a Potential Target for Treating Glioblastoma
por: Berney, Ethan, et al.
Publicado: (2019)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
por: Johnson, Rebecca, et al.
Publicado: (2013)

Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness
por: Dossou, Akpedje S., et al.
Publicado: (2023)

HDL as a drug and nucleic acid delivery vehicle
por: Lacko, Andras G., et al.
Publicado: (2015)

Targeted Drug Discovery for Pediatric Leukemia
por: Napper, Andrew D., et al.
Publicado: (2013)

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics
por: Cruz, Pedro M. R., et al.
Publicado: (2013)

Antibody Therapy for Pediatric Leukemia
por: Vedi, Aditi, et al.
Publicado: (2014)

The Biology and Targeting of FLT3 in Pediatric Leukemia
por: Annesley, Colleen E., et al.
Publicado: (2014)

Immunotherapy for Pediatric Leukemia
por: Shah, Nirali N., et al.
Publicado: (2013)

Challenges of Clinical Trial Design for Targeted Agents Against Pediatric Leukemias
por: Mussai, Francis Jay, et al.
Publicado: (2015)

Inhibitor of Apoptosis Proteins in Pediatric Leukemia: Molecular Pathways and Novel Approaches to Therapy
por: Fulda, Simone
Publicado: (2014)

Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
por: Panina, Svetlana B., et al.
Publicado: (2020)

Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
por: Jacoby, Elad, et al.
Publicado: (2014)

Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
por: Orentas, Rimas J., et al.
Publicado: (2014)

Pediatric Medulloblastoma – Update on Molecular Classification Driving Targeted Therapies
por: DeSouza, Ruth-Mary, et al.
Publicado: (2014)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
por: Huang, Wanxue, et al.
Publicado: (2022)

Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia
por: Yi, Xue, et al.
Publicado: (2022)

Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer
por: Wagner, Michael J., et al.
Publicado: (2013)

Immunotherapy Targets in Pediatric Cancer
por: Orentas, Rimas J., et al.
Publicado: (2012)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

A Review of Targeted Therapies Evaluated by the Pediatric Preclinical Testing Program for Osteosarcoma
por: Sampson, Valerie B., et al.
Publicado: (2013)

Targeting CD38 for acute leukemia
por: Zhong, Xushu, et al.
Publicado: (2022)

Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Bernt, Kathrin M., et al.
Publicado: (2014)

The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies
por: Shen, Colette J., et al.
Publicado: (2021)

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia
por: Gupta, Sumit, et al.
Publicado: (2023)

Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges
por: Grünewald, Thomas G. P., et al.
Publicado: (2016)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2019)

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers
por: Duffy, Caitlyn, et al.
Publicado: (2023)

Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy
por: Janko, Christina, et al.
Publicado: (2019)

Tissue Factor-Targeted “O(2)-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma
por: Li, Ziying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p1jj3ccm0vf86divaeo2r3nlkl